SEC Form 4 · accession 0000899243-16-024761
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel P Sears Jr.
Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 7, 2016 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Jun 30, 2016 | A | 30,000 | A | — | Aug 12, 2017 | Common Stock | 30,000 | 30,000 | D |
| Stock OptionsF2 | $2.34 | Jun 30, 2016 | A | 15,000 | A | — | Jun 30, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") were issued to the Reporting Person on June 30, 2016, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 15,000 RSUs vest in the first open window following the Company's 2016 Annual Meeting of Stockholders and (b) 15,000 RSUs vest in the first open window following the Company's 2017 Annual Meeting of Stockholders.
- F2The stock options ("options") were issued to the Reporting Person on June 30, 2016, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 7,500 RSUs vest in the first open window following the Company's 2016 Annual Meeting of Stockholders and (b) 7,500 RSUs vest in the first open window following the Company's 2017 Annual Meeting of Stockholders.